子痫前期与静脉血栓栓塞症的长期风险
该观察性队列研究利用丹麦全国登记数据,纳入1997年1月1日至2016年12月31日分娩的522 545例初产妇,其中23 330例(4.5%)诊断为子痫前期,中位随访10.2年。子痫前期组VTE发生率448.8/1000人年 vs 无子痫前期组309.6/1000人年,未调整HR 1.45(95%CI 1.29-1.63),调整后HR 1.43(95%CI 1.27-1.61);深静脉血栓调整HR 1.49(95%CI 1.31-1.70),肺栓塞调整HR 1.36(95%CI 1.08-1.73)。妊娠期、产褥期及产褥期后的landmark分析结果一致。作者认为未来研究应探讨如何改善有子痫前期病史女性的临床管理以预防VTE。
要点
- 子痫前期初产妇VTE发生率448.8/1000人年 vs 无子痫前期309.6/1000人年,调整HR 1.43(95%CI 1.27-1.61)。
- 子痫前期与深静脉血栓风险升高相关(调整HR 1.49,95%CI 1.31-1.70),与肺栓塞风险升高相关(调整HR 1.36,95%CI 1.08-1.73)。
- 风险在妊娠期、产褥期及产褥期后的landmark分析中均持续存在,提示产后长期风险不应忽视。
- 中位随访10.2年(IQR 5.2-15.4年),有子痫前期病史的女性可能在产后多年仍处于VTE风险升高状态。
- 作者认为未来研究应探讨如何改善有子痫前期病史女性的临床管理以预防VTE。
适用人群与场景
- 1997年1月1日至2016年12月31日在丹麦分娩的所有符合条件的初产妇,共522 545例,中位年龄28岁(IQR 25-31岁)。
- 暴露组为初次妊娠期间诊断子痫前期者23 330例(4.5%);对照组为无子痫前期者。
- 随访从初次妊娠至发生VTE、移民、死亡或研究结束(2016年12月31日)。
研究设计与关键结果
- 研究类型:观察性队列研究,利用丹麦全国登记数据,纳入522 545例初产妇,其中23 330例(4.5%)诊断为子痫前期。
- 主要终点:子痫前期组VTE发生率448.8/1000人年(95%CI 399.9-503.5) vs 无子痫前期组309.6/1000人年(95%CI 300.6-319.9),未调整HR 1.45(95%CI 1.29-1.63),调整HR 1.43(95%CI 1.27-1.61)。
- 深静脉血栓:未调整HR 1.51(95%CI 1.32-1.72),调整HR 1.49(95%CI 1.31-1.70)。
- 肺栓塞:未调整HR 1.39(95%CI 1.09-1.76),调整HR 1.36(95%CI 1.08-1.73)。
- landmark分析显示上述关联在妊娠期、产褥期及产褥期后均成立。
- 中位随访10.2年(IQR 5.2-15.4年),子痫前期组与无子痫前期组年龄相似,但合并症负担更高。
证据类型、等级与局限
- 证据类型:观察性队列研究(丹麦全国登记数据)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为未来研究应探讨如何改善有子痫前期病史女性的临床管理以预防VTE。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: As venous thromboembolism (VTE) remains one of the leading causes of maternal mortality, identifying women at increased risk of VTE is of great importance. Preeclampsia is a pregnancy-induced hypertensive disorder with generalized endothelial dysfunction. Some studies suggest that preeclampsia is associated with an increased risk of VTE, but much controversy exists.
OBJECTIVE: To examine the association between preeclampsia and the risk of VTE during pregnancy, during the puerperium, and after the puerperium.
DESIGN, SETTING, AND PARTICIPANTS: This observational cohort study used Danish nationwide registries to identify all eligible primiparous women who gave birth in Denmark from January 1, 1997, to December 31, 2016. The women were followed up from primiparous pregnancy to incident VTE, emigration, death, or the end of the study (December 31, 2016). Statistical analyses were carried out from January to May 2023.
EXPOSURE: Preeclampsia during primiparous pregnancy.
MAIN OUTCOMES AND MEASURE: The main outcome was incident VTE, and the secondary outcome was all-cause mortality.
RESULTS: A total of 522 545 primiparous women (median age, 28 years [IQR, 25-31 years]) were included, and 23 330 (4.5%) received a diagnosis of preeclampsia. Women with preeclampsia were of similar age to women without preeclampsia but had a higher burden of comorbidities. During a median follow-up of 10.2 years (IQR, 5.2-15.4 years), preeclampsia was associated with a higher incidence of VTE compared with no preeclampsia (incidence rate, 448.8 [95% CI, 399.9-503.5] vs 309.6 [95% CI, 300.6-319.9] per 1000 patient-years, corresponding to an unadjusted hazard ratio [HR] of 1.45 [95% CI, 1.29-1.63] and an adjusted HR of 1.43 [95% CI, 1.27-1.61]). When stratified according to the subcategories of VTE, preeclampsia was associated with an increased rate of deep vein thrombosis (unadjusted HR, 1.51 [95% CI, 1.32-1.72] and adjusted HR, 1.49 [95% CI, 1.31-1.70]) as well as pulmonary embolism (unadjusted HR, 1.39 [95% CI, 1.09-1.76]; adjusted HR, 1.36 [95% CI, 1.08-1.73]). These findings held true in landmark analyses during pregnancy, during the puerperium, and after the puerperium.
CONCLUSIONS AND RELEVANCE: This cohort study suggests that preeclampsia was associated with a significantly increased risk of VTE during pregnancy, during the puerperium, and after the puerperium, even after thorough adjustment. Future studies should address how to improve the clinical management of women with a history of preeclampsia to prevent VTE.
参考来源
- Havers-Borgersen E, Butt JH, Johansen M, et al. Preeclampsia and Long-Term Risk of Venous Thromboembolism. JAMA Netw Open. 2023. PMID: 37976060. doi:10.1001/jamanetworkopen.2023.43804
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。